Document is current

Article History

Received: 8 October 2019

Accepted: 23 March 2020

First Online: 30 April 2020

Compliance with ethical standards

:

: PJM reports receiving grant support from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Janssen, Lilly, Novartis, Pfizer, Sun, and UCB; consulting fees from AbbVie, Amgen, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, Sun, and UCB; and speaker fees from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Janssen, Lilly, Novartis, Pfizer, and UCB. IBM reports receiving research grants from Bristol-Myers Squibb, Celgene, Janssen, Novartis, and UCB; and consulting fees from AbbVie, Bristol-Myers Squibb, Celgene, Janssen, Novartis, and UCB. VS reports receiving consulting fees from AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Celltrion, Corrona, Crescendo, Genentech/Roche, GlaxoSmithKline, Janssen, Lilly, Merck, Novartis, Pfizer, Regeneron, Samsung, Sandoz, Sanofi, and UCB. OF reports receiving research grants from Bristol-Myers Squibb. HAA and SB are employees of Bristol-Myers Squibb and report holding stock in Bristol-Myers Squibb. YE is consultant for Bristol-Myers Squibb.

: Schulman Associates Institutional Review Board or Independent Ethics Committees approved the protocol, consent form, and any other written information provided to patients or their legal representatives.

: All patients gave written informed consent prior to study entry.